Integrated Filing — IndAS



General information about company

Scrip Code 532321
NSE Symbol ZYDUSLIFE
MSEI Symbol NOTLISTED
ISIN INE010B01027
Name of company ZYDUS LIFESCIENCES LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 06-11-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 29-10-2025
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Second quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Single segment
Description of single segment Pharmaceuticals
Start date and time of board meeting 06-11-2025   11:00:00
End date and time of board meeting 06-11-2025   13:00:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 24-03-2025
Indicate Company website link for updated RPT policy of the Company www.zyduslife.com
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
There has been no default.



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2025 01-04-2025
B Date of end of reporting period 30-09-2025 30-09-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 2,87,120.00 5,45,950.00
Other income 54,150.00 69,860.00
Total income 3,41,270.00 6,15,810.00
2 Expenses
(a) Cost of materials consumed 89,080.00 1,74,450.00
(b) Purchases of stock-in-trade 4,450.00 10,060.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (9,230.00) (9,830.00)
(d) Employee benefit expense 46,870.00 95,590.00
(e) Finance costs 11,380.00 25,140.00
(f) Depreciation, depletion and amortisation expense 13,600.00 26,600.00
(f) Other Expenses
1 Other expenses 80,340.00 1,45,150.00
2 Net (gain) on foreign currency transactions (39,580.00) (43,200.00)
Total other expenses 40,760.00 1,01,950.00
Total expenses 1,96,910.00 4,23,960.00
3 Total profit before exceptional items and tax 1,44,360.00 1,91,850.00
4 Exceptional items 0.00 0.00
5 Total profit before tax 1,44,360.00 1,91,850.00
6 Tax expense
7 Current tax 28,170.00 37,130.00
8 Deferred tax 530.00 590.00
9 Total tax expenses 28,700.00 37,720.00
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 1,15,660.00 1,54,130.00
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 1,15,660.00 1,54,130.00
17 Other comprehensive income net of taxes 1,620.00 1,720.00
18 Total Comprehensive Income for the period 1,17,280.00 1,55,850.00
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 10,060.00 10,060.00
Face value of equity share capital 1 1
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 11.49 15.32
Diluted earnings (loss) per share from continuing operations 11.49 15.32
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 11.49 15.32
Diluted earnings (loss) per share from continuing and discontinued operations 11.49 15.32
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 30-09-2025
Whether results are audited or unaudited Unaudited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 4,47,720.00
Capital work-in-progress 1,00,450.00
Investment property 0.00
Goodwill 0.00
Other intangible assets 6,970.00
Intangible assets under development 0.00
Biological assets other than bearer plants 0.00
Investments accounted for using equity method 0.00
Non-current financial assets
Non-current investments 7,54,730.00
Trade receivables, non-current 0.00
Loans, non-current 4,05,850.00
Other non-current financial assets 1,390.00
Total non-current financial assets 11,61,970.00
Deferred tax assets (net) 0.00
Other non-current assets 29,460.00
Total non-current assets 17,46,570.00
2 Current assets
Inventories 1,95,980.00
Current financial asset
Current investments 2,86,480.00
Trade receivables, current 8,47,860.00
Cash and cash equivalents 6,640.00
Bank balance other than cash and cash equivalents 4,110.00
Loans, current 11,280.00
Other current financial assets 45,440.00
Total current financial assets 12,01,810.00
Current tax assets (net) 0.00
Other current assets 39,490.00
Total current assets 14,37,280.00
3 Non-current assets classified as held for sale 0.00
4 Regulatory deferral account debit balances and related deferred tax Assets 0.00
Total assets 31,83,850.00
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 10,060.00
Other equity 21,54,110.00
Total equity attributable to owners of parent 21,64,170.00
Non controlling interest
Total equity 21,64,170.00
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 3,43,530.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0.00
Total Trade payable 0.00
Other non-current financial liabilities 3,330.00
Total non-current financial liabilities 3,46,860.00
Provisions, non-current 26,600.00
Deferred tax liabilities (net) 14,920.00
Deferred government grants, Non-current 0.00
Other non-current liabilities 0.00
Total non-current liabilities 3,88,380.00
Current liabilities
Current financial liabilities
Borrowings, current 4,24,420.00
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 7,400.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 1,25,630.00
Total Trade payable 1,33,030.00
Other current financial liabilities 42,800.00
Total current financial liabilities 6,00,250.00
Other current liabilities 15,770.00
Provisions, current 12,750.00
Current tax liabilities (Net) 2,530.00
Deferred government grants, Current 0.00
Total current liabilities 6,31,300.00
3 Liabilities directly associated with assets in disposal group classified as held for sale 0.00
4 Regulatory deferral account credit balances and related deferred tax liability 0.00
Total liabilities 10,19,680.00
Total equity and liabilites 31,83,850.00
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-07-2025 01-04-2025
Date of end of reporting period 30-09-2025 30-09-2025
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2025 01-04-2025
B Date of end of reporting period 30-09-2025 30-09-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Items that will not be reclassified to profit or loss 1,510.00 1,490.00
Total Amount of items that will not be reclassified to profit and loss 1,510.00 1,490.00
2 Income tax relating to items that will not be reclassified to profit or loss (110.00) (230.00)
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 0.00 0.00
5 Total Other comprehensive income 1,620.00 1,720.00



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2025
B Date of end of reporting period 30-09-2025
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Standalone
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 1,91,850.00
Adjustments for reconcile profit (loss)
Adjustments for finance costs 25,000.00
Adjustments for decrease (increase) in inventories (770.00)
Adjustments for decrease (increase) in trade receivables, current (9,690.00)
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets (13,230.00)
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current 0.00
Adjustments for other financial assets, current 0.00
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current 7,120.00
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities (5,830.00)
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 26,600.00
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current 660.00
Adjustments for provisions, non-current 2,560.00
Adjustments for other financial liabilities, current 0.00
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains (37,340.00)
Adjustments for dividend income 42,080.00
Adjustments for interest income 23,940.00
Adjustments for share-based payments 0.00
Adjustments for fair value losses (gains) (3,980.00)
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 250.00
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items 5,430.00
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) (69,240.00)
Net cash flows from (used in) operations 1,22,610.00
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 77,010.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 45,600.00
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 26,810.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 250.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 460.00
Purchase of property, plant and equipment 44,270.00
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 34,300.00
Cash receipts from repayment of advances and loans made to other parties 54,470.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 41,830.00
Interest received 25,080.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 1,41,150.00
Net cash flows from (used in) investing activities 1,57,360.00
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 1,94,520.00
Repayments of borrowings 2,61,010.00
Payments of lease liabilities 90.00
Dividends paid 1,10,570.00
Interest paid 29,470.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities (2,06,620.00)
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes (3,660.00)
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents (3,660.00)
Cash and cash equivalents cash flow statement at beginning of period 10,300.00
Cash and cash equivalents cash flow statement at end of period 6,640.00





Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)
Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Zydus Lifesciences Limited Zydus Pharmaceuticals Limited Subsidiary Company Purchase of goods or services 1,019.60 Amount as approved by the Audit Committee. 1,019.60 0.00 0.00 Textual Information(1)
2 Zydus Lifesciences Limited Zydus Healthcare Limited Subsidiary Company Purchase of goods or services 703.30 Amount as approved by the Audit Committee. 703.30 0.00 0.00
3 Zydus Lifesciences Limited Zydus Healthcare S.A. (Pty) Ltd Subsidiary Company Purchase of goods or services 7.30 Amount as approved by the Audit Committee. 7.30 0.00 0.00
4 Zydus Lifesciences Limited Zydus Pharmaceuticals Mexico SA De CV Subsidiary Company Purchase of goods or services 1.80 Amount as approved by the Audit Committee. 1.80 0.00 0.00
5 Zydus Lifesciences Limited Zydus Nikkho Farmaceutica Ltda. Subsidiary Company Purchase of goods or services 15.60 Amount as approved by the Audit Committee. 15.60 0.00 0.00
6 Zydus Lifesciences Limited Zydus Healthcare (USA) LLC Subsidiary Company Purchase of goods or services 1,002.80 Amount as approved by the Audit Committee. 1,002.80 0.00 0.00
7 Zydus Lifesciences Limited Zydus Animal Health and Investments Limited Subsidiary Company Purchase of goods or services 0.20 Amount as approved by the Audit Committee. 0.20 0.00 0.00
8 Zydus Lifesciences Limited Zydus Hospira Oncology Private Limited Joint Ventures Purchase of goods or services 249.20 Amount as approved by the Audit Committee. 249.20 0.00 0.00
9 Zydus Lifesciences Limited Sterling Biotech Limited Joint Ventures Purchase of goods or services 281.20 Amount as approved by the Audit Committee. 281.20 0.00 0.00
10 Zydus Lifesciences Limited Cadmach Machinery Company Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 53.90 Amount as approved by the Audit Committee. 53.90 0.00 0.00
11 Zydus Lifesciences Limited Oneiro Chemicals Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 4,364.50 Amount as approved by the Audit Committee. 4,364.50 0.00 0.00
12 Zydus Lifesciences Limited Zydus VTEC Limited Subsidiary Company Purchase of fixed assets 236.40 Amount as approved by the Audit Committee. 236.40 0.00 0.00
13 Zydus Lifesciences Limited Cadmach Machinery Company Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of fixed assets 176.30 Amount as approved by the Audit Committee. 176.30 0.00 0.00
14 Zydus Lifesciences Limited Zydus Wellness Products Limited Subsidiary Company Purchase of goods or services 1.40 Amount as approved by the Audit Committee. 1.40 0.00 0.00
15 Zydus Lifesciences Limited German Remedies Pharma Private Limited Subsidiary Company Purchase of goods or services 11.70 Amount as approved by the Audit Committee. 11.70 0.00 0.00
16 Zydus Lifesciences Limited Zydus Pharmaceuticals Limited Subsidiary Company Purchase of goods or services 2,418.80 Amount as approved by the Audit Committee. 2,418.80 0.00 0.00
17 Zydus Lifesciences Limited Zydus Healthcare Limited Subsidiary Company Purchase of goods or services 313.10 Amount as approved by the Audit Committee. 313.10 0.00 0.00
18 Zydus Lifesciences Limited Zydus Medtech France SAS Subsidiary Company Sale of goods or services 301.70 Amount as approved by the Audit Committee. 301.70 0.00 0.00
19 Zydus Lifesciences Limited Zydus Medtech France SAS Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 301.70
20 Zydus Lifesciences Limited Vitely Corp Pvt Ltd (Formerly Known Vitely Bio LLP) Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 111.70 Amount as approved by the Audit Committee. 111.70 0.00 0.00
21 Zydus Lifesciences Limited Zydus Hospitals and Healthcare Research Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 2.60 Amount as approved by the Audit Committee. 2.60 0.00 0.00
22 Zydus Lifesciences Limited Cadmach Machinery Company Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 22.00 Amount as approved by the Audit Committee. 22.00 0.00 0.00
23 Zydus Lifesciences Limited Mukesh M. Patel & Co., Proprietorship Firm Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 50.00 Amount as approved by the Audit Committee. 50.00 0.00 0.00
24 Zydus Lifesciences Limited International Tax & Investment Consultants-Proprietorship Firm Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 33.30 Amount as approved by the Audit Committee. 33.30 0.00 0.00
25 Zydus Lifesciences Limited TUV India Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0.50 Amount as approved by the Audit Committee. 0.50 0.00 0.00
26 Zydus Lifesciences Limited Apollo Healthco Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.00 3.90
27 Zydus Lifesciences Limited Apollo Healthco Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 23.30 Amount as approved by the Audit Committee. 23.30 0.00 0.00
28 Zydus Lifesciences Limited Zydus Infrastructure Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 740.00 Amount as approved by the Audit Committee. 740.00 0.00 0.00
29 Zydus Lifesciences Limited Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Any other transaction Reimbursement of Expenses paid 8,381.90 Amount as approved by the Audit Committee. 8,381.90 0.00 0.00
30 Zydus Lifesciences Limited Zydus Healthcare (USA) LLC Subsidiary Company Any other transaction Reimbursement of Expenses paid 182.20 Amount as approved by the Audit Committee. 182.20 0.00 0.00
31 Zydus Lifesciences Limited Zydus Healthcare S.A. (Pty) Ltd Subsidiary Company Any other transaction Reimbursement of Expenses paid 179.00 Amount as approved by the Audit Committee. 179.00 0.00 0.00
32 Zydus Lifesciences Limited Zydus Pharmaceuticals Mexico SA De CV Subsidiary Company Any other transaction Reimbursement of Expenses paid 38.50 Amount as approved by the Audit Committee. 38.50 0.00 0.00
33 Zydus Lifesciences Limited Zydus France, SAS Subsidiary Company Any other transaction Reimbursement of Expenses paid 1,288.20 Amount as approved by the Audit Committee. 1,288.20 0.00 0.00
34 Zydus Lifesciences Limited Laboratorios Combix S.L. Subsidiary Company Any other transaction Reimbursement of Expenses paid 868.20 Amount as approved by the Audit Committee. 868.20 0.00 0.00
35 Zydus Lifesciences Limited Zydus Lanka (Private) Limited Subsidiary Company Any other transaction Reimbursement of Expenses paid 4.80 Amount as approved by the Audit Committee. 4.80 0.00 0.00
36 Zydus Lifesciences Limited Zydus Nikkho Farmaceutica Ltda. Subsidiary Company Any other transaction Reimbursement of Expenses paid 36.30 Amount as approved by the Audit Committee. 36.30 0.00 0.00
37 Zydus Lifesciences Limited Zydus Pharmaceuticals UK Ltd. Subsidiary Company Any other transaction Reimbursement of Expenses paid 733.90 Amount as approved by the Audit Committee. 733.90 0.00 0.00
38 Zydus Lifesciences Limited Zydus Hospitals and Healthcare Research Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Reimbursement of Expenses paid 0.80 Amount as approved by the Audit Committee. 0.80 0.00 0.00
39 Zydus Lifesciences Limited Zydus Hospira Oncology Private Limited Joint Ventures Any other transaction Reimbursement of Expenses paid 18.50 Amount as approved by the Audit Committee. 18.50 0.00 0.00
40 Zydus Lifesciences Limited Zydus Animal Health and Investments Limited Subsidiary Company Sale of goods or services 1.70 Amount as approved by the Audit Committee. 1.70 0.00 0.00
41 Zydus Lifesciences Limited Zydus Pharmaceuticals Limited Subsidiary Company Sale of goods or services 3,926.90 Amount as approved by the Audit Committee. 3,926.90 0.00 0.00
42 Zydus Lifesciences Limited Zydus Healthcare Limited Subsidiary Company Sale of goods or services 5,110.00 Amount as approved by the Audit Committee. 5,110.00 0.00 0.00
43 Zydus Lifesciences Limited Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Sale of goods or services 2,72,466.30 Amount as approved by the Audit Committee. 2,72,466.30 0.00 0.00
44 Zydus Lifesciences Limited Viona Pharmaceuticals INC Subsidiary Company Sale of goods or services 22,922.30 Amount as approved by the Audit Committee. 22,922.30 0.00 0.00
45 Zydus Lifesciences Limited Zydus Healthcare Philippines Inc. Subsidiary Company Sale of goods or services 4,659.90 Amount as approved by the Audit Committee. 4,659.90 0.00 0.00
46 Zydus Lifesciences Limited Alidac Healthcare (Myanmar) Limited Subsidiary Company Sale of goods or services 764.30 Amount as approved by the Audit Committee. 764.30 0.00 0.00
47 Zydus Lifesciences Limited Zydus Healthcare S.A. (Pty) Ltd Subsidiary Company Sale of goods or services 4,416.30 Amount as approved by the Audit Committee. 4,416.30 0.00 0.00
48 Zydus Lifesciences Limited Zydus Pharmaceuticals Mexico SA De CV Subsidiary Company Sale of goods or services 8,276.60 Amount as approved by the Audit Committee. 8,276.60 0.00 0.00
49 Zydus Lifesciences Limited Zydus Nikkho Farmaceutica Ltda. Subsidiary Company Sale of goods or services 5,508.30 Amount as approved by the Audit Committee. 5,508.30 0.00 0.00
50 Zydus Lifesciences Limited Zydus France, SAS Subsidiary Company Sale of goods or services 5,574.80 Amount as approved by the Audit Committee. 5,574.80 0.00 0.00
51 Zydus Lifesciences Limited Laboratorios Combix S.L. Subsidiary Company Sale of goods or services 3,059.90 Amount as approved by the Audit Committee. 3,059.90 0.00 0.00
52 Zydus Lifesciences Limited Zydus Worldwide DMCC Subsidiary Company Sale of goods or services 2,553.90 Amount as approved by the Audit Committee. 2,553.90 0.00 0.00
53 Zydus Lifesciences Limited Zydus Lifesciences Global FZE [UAE] Subsidiary Company Sale of goods or services 15,223.30 Amount as approved by the Audit Committee. 15,223.30 0.00 0.00
54 Zydus Lifesciences Limited Zydus Takeda Healthcare Private Limited Joint Ventures Sale of goods or services 1,042.50 Amount as approved by the Audit Committee. 1,042.50 0.00 0.00
55 Zydus Lifesciences Limited Zydus Hospitals and Healthcare Research Private Limited Enterprises significantly influenced by Directors and/ or their relatives Sale of goods or services 124.00 Amount as approved by the Audit Committee. 124.00 0.00 0.00
56 Zydus Lifesciences Limited Zydus Hospitals and Healthcare Research Private Limited Enterprises significantly influenced by Directors and/ or their relatives Sale of goods or services 8.00 Amount as approved by the Audit Committee. 8.00 0.00 0.00
57 Zydus Lifesciences Limited German Remedies Pharma Private Limited Subsidiary Company Loan 0.00 N.A. 10,000.00 0.00 0.00
58 Zydus Lifesciences Limited Zydus Pharmaceuticals Limited Subsidiary Company Purchase of fixed assets 2.20 Amount as approved by the Audit Committee. 2.20 0.00 0.00
59 Zydus Lifesciences Limited Alidac Healthcare (Myanmar) Limited Subsidiary Company Sale of goods or services 112.90 Amount as approved by the Audit Committee. 112.90 0.00 0.00
60 Zydus Lifesciences Limited Zydus Wellness Limited Subsidiary Company Sale of goods or services 43.60 Amount as approved by the Audit Committee. 43.60 0.00 0.00
61 Zydus Lifesciences Limited Zydus Wellness Products Limited Subsidiary Company Sale of goods or services 111.60 Amount as approved by the Audit Committee. 111.60 0.00 0.00
62 Zydus Lifesciences Limited German Remedies Pharma Private Limited Subsidiary Company Sale of goods or services 33.40 Amount as approved by the Audit Committee. 33.40 0.00 0.00
63 Zydus Lifesciences Limited Zydus Animal Health and Investments Limited Subsidiary Company Sale of goods or services 48.70 Amount as approved by the Audit Committee. 48.70 0.00 0.00
64 Zydus Lifesciences Limited Zydus Pharmaceuticals Limited Subsidiary Company Sale of goods or services 11.30 Amount as approved by the Audit Committee. 11.30 0.00 0.00
65 Zydus Lifesciences Limited Zydus VTEC Limited Subsidiary Company Sale of goods or services 175.30 Amount as approved by the Audit Committee. 175.30 0.00 0.00
66 Zydus Lifesciences Limited Zydus Healthcare Limited Subsidiary Company Sale of goods or services 1,782.80 Amount as approved by the Audit Committee. 1,782.80 0.00 0.00
67 Zydus Lifesciences Limited Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Sale of goods or services 193.30 Amount as approved by the Audit Committee. 193.30 0.00 0.00
68 Zydus Lifesciences Limited Viona Pharmaceuticals INC Subsidiary Company Sale of goods or services 50.20 Amount as approved by the Audit Committee. 50.20 0.00 0.00
69 Zydus Lifesciences Limited Zydus Therapeutics INC Subsidiary Company Sale of goods or services 367.40 Amount as approved by the Audit Committee. 367.40 0.00 0.00
70 Zydus Lifesciences Limited Zydus Worldwide DMCC Subsidiary Company Sale of goods or services 5.10 Amount as approved by the Audit Committee. 5.10 0.00 0.00
71 Zydus Lifesciences Limited Zydus Pharmaceuticals UK Ltd. Subsidiary Company Sale of goods or services 301.10 Amount as approved by the Audit Committee. 301.10 0.00 0.00
72 Zydus Lifesciences Limited Zydus Lifesciences Global FZE [UAE] Subsidiary Company Sale of goods or services 1,151.60 Amount as approved by the Audit Committee. 1,151.60 0.00 0.00
73 Zydus Lifesciences Limited Zydus Medtech Private Limited Subsidiary Company Investment 0.00 N.A. 2,100.00 13,950.00 16,050.00 Investment 0 N.A Unsecured Business Purpose Textual Information(2)
74 Zydus Lifesciences Limited Zydus Medtech Private Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 24.00 22.00
75 Zydus Lifesciences Limited Zydus Medtech Private Limited Subsidiary Company Sale of goods or services 0.60 Amount as approved by the Audit Committee. 0.60 0.00 0.00
76 Zydus Lifesciences Limited Zydus Animal Health and Investments Limited Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 481.00 Amount as approved by the Audit Committee. 481.00 0.00 0.00
77 Zydus Lifesciences Limited Zydus Lifesciences Global FZE [UAE] Subsidiary Company Interest received 0.00 N.A. 1,012.50 0.00 0.00
78 Zydus Lifesciences Limited Zydus Lifesciences Global FZE [UAE] Subsidiary Company Loan 0.00 N.A. 12,918.80 0.00 0.00 Loan 2.400 5 Year Unsecured Business Purpose Textual Information(3)
79 Zydus Lifesciences Limited Zydus Lifesciences Global FZE [UAE] Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 17,146.50 32,144.50
80 Zydus Lifesciences Limited Zydus Lifesciences Global FZE [UAE] Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 1,597.00 Amount as approved by the Audit Committee. 1,597.00 0.00 0.00
81 Zydus Lifesciences Limited Zydus Wellness Limited Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 13.20 Amount as approved by the Audit Committee. 13.20 0.00 0.00
82 Zydus Lifesciences Limited Zydus Wellness Products Limited Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 100.20 Amount as approved by the Audit Committee. 100.20 0.00 0.00
83 Zydus Lifesciences Limited Mr. Pankaj R. Patel Key Managerial Personnel Any other transaction Director Sitting Fees 0.00 N.A. 6.00 0.00 0.00
84 Zydus Lifesciences Limited Dr. Sharvil P. Patel Key Managerial Personnel Remuneration 0.00 N.A. 1,800.00 0.00 0.00
85 Zydus Lifesciences Limited Mr. Ganesh N. Nayak Key Managerial Personnel Remuneration 0.00 N.A. 280.30 0.00 0.00
86 Zydus Lifesciences Limited Mr. Nitin D. Parekh Key Managerial Personnel Remuneration 0.00 N.A. 365.80 0.00 0.00
87 Zydus Lifesciences Limited Mr. Tushar D. Shroff Key Managerial Personnel Remuneration 0.00 N.A. 26.80 0.00 0.00
88 Zydus Lifesciences Limited Mr. Dhaval N. Soni Key Managerial Personnel Remuneration 0.00 N.A. 26.10 0.00 0.00
89 Zydus Lifesciences Limited Dialforhealth Unity Limited Subsidiary Company Interest received 0.00 N.A. 0.90 0.00 0.00
90 Zydus Lifesciences Limited Zydus International Private Limited Subsidiary Company Interest received 0.00 N.A. 3,051.60 0.00 0.00
91 Zydus Lifesciences Limited Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Interest received 0.00 N.A. 2,297.20 0.00 0.00
92 Zydus Lifesciences Limited Sentynl Therapeutics Inc. Subsidiary Company Interest received 0.00 N.A. 3,140.30 0.00 0.00
93 Zydus Lifesciences Limited Zydus Worldwide DMCC Subsidiary Company Interest received 0.00 N.A. 824.70 0.00 0.00
94 Zydus Lifesciences Limited Zydus Pharmaceuticals UK Ltd. Subsidiary Company Sale of goods or services 496.70 Amount as approved by the Audit Committee. 496.70 0.00 0.00
95 Zydus Lifesciences Limited Zydus Pharmaceuticals UK Ltd. Subsidiary Company Interest received 0.00 N.A. 426.60 0.00 0.00
96 Zydus Lifesciences Limited German Remedies Pharma Private Limited Subsidiary Company Interest paid 0.00 N.A. 335.10 0.00 0.00
97 Zydus Lifesciences Limited Zydus Animal Health and Investments Limited Subsidiary Company Interest paid 0.00 N.A. 3,726.00 0.00 0.00
98 Zydus Lifesciences Limited Zydus Healthcare Limited Subsidiary Company Interest paid 0.00 N.A. 12,542.10 0.00 0.00
99 Zydus Lifesciences Limited Zydus Takeda Healthcare Private Limited Joint Ventures Dividend received 0.00 N.A. 2,000.10 0.00 0.00
100 Zydus Lifesciences Limited Zydus Hospira Oncology Private Limited Joint Ventures Dividend received 0.00 N.A. 2,000.00 0.00 0.00
101 Zydus Lifesciences Limited Zydus Pharmaceuticals UK Ltd. Subsidiary Company Loan 0.00 N.A. 21,377.70 0.00 0.00 Loan 1.900 5 Year Unsecured Business Purpose Textual Information(4)
102 Zydus Lifesciences Limited LM Manufacturing India Private Limited Subsidiary Company Interest received 0.00 N.A. 1.50 0.00 0.00
103 Zydus Lifesciences Limited LM Manufacturing India Private Limited Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 44.30 44.90
104 Zydus Lifesciences Limited Zydus Pharmaceuticals Limited Subsidiary Company Investment 0.00 N.A. 22,500.00 76,000.00 98,500.00 Investment 0 N.A Unsecured Business Purpose Textual Information(5)
105 Zydus Lifesciences Limited Zydus Pharmaceuticals Canada Inc. Subsidiary Company Any other transaction Reimbursement of Expenses paid 44.50 Amount as approved by the Audit Committee. 44.50 0.00 0.00
106 Zydus Lifesciences Limited Zydus Pharmaceuticals Canada Inc. Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.00 11.70
107 Zydus Lifesciences Limited Zynext Ventures Pte. Ltd. Subsidiary Company Investment 0.00 N.A. 0.00 7,965.30 0.00
108 Zydus Lifesciences Limited Zydus Healthcare Limited Subsidiary Company Loan 0.00 N.A. 1,36,835.90 0.00 0.00
109 Zydus Lifesciences Limited Zydus Worldwide DMCC Subsidiary Company Loan 0.00 N.A. 54,465.20 0.00 0.00
110 Zydus Lifesciences Limited Zydus Animal Health and Investments Limited Subsidiary Company Loan 0.00 N.A. 71,009.10 0.00 0.00
111 Zydus Lifesciences Limited Cadila Healthcare Ltd. Managerial Cadre EPF Post Employment Benefit Plans Any other transaction Contributions during the year [includes Employee's share and contribution] 0.00 N.A. 3,852.60 0.00 0.00
112 Zydus Lifesciences Limited Cadila Healthcare Limited Employees Group Gratuity Scheme Post Employment Benefit Plans Any other transaction Contributions during the year [includes Employee's share and contribution] 0.00 N.A. 157.00 0.00 0.00
113 Zydus Lifesciences Limited Zydus Animal Health and Investments Limited Subsidiary Company Any other transaction Outstanding Payables - Loans 0.00 N.A. 0.00 1,14,513.50 1,17,775.80
114 Zydus Lifesciences Limited Zydus Healthcare Limited Subsidiary Company Any other transaction Outstanding Payables - Loans 0.00 N.A. 0.00 4,23,469.50 3,92,795.50
115 Zydus Lifesciences Limited German Remedies Pharma Private Limited Subsidiary Company Any other transaction Outstanding Payables - Loans 0.00 N.A. 0.00 10,354.20 10,001.70
116 Zydus Lifesciences Limited Zydus Pharmaceuticals Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 4,424.20 2,578.80
117 Zydus Lifesciences Limited Zydus VTEC Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 113.50 289.00
118 Zydus Lifesciences Limited Zydus Healthcare Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 3,789.20 2,436.50
119 Zydus Lifesciences Limited Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 6,501.70 9,111.00
120 Zydus Lifesciences Limited Zydus Healthcare (USA) LLC Subsidiary Company Investment 0.00 N.A. 2,206.80 0.00 2,206.80 Investment 0 N.A Unsecured Business Purpose Textual Information(6)
121 Zydus Lifesciences Limited Zydus Healthcare (USA) LLC Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 619.40 411.20
122 Zydus Lifesciences Limited Viona Pharmaceuticals INC Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 752.20 838.70
123 Zydus Lifesciences Limited Zydus Healthcare S.A. (Pty) Ltd Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 2,905.40 3,113.20
124 Zydus Lifesciences Limited Zydus Pharmaceuticals Mexico SA De CV Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 595.70 685.40
125 Zydus Lifesciences Limited Zydus Nikkho Farmaceutica Ltda. Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 788.90 876.50
126 Zydus Lifesciences Limited Zydus France, SAS Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 2,485.50 3,178.60
127 Zydus Lifesciences Limited Zydus Lanka (Private) Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 16.40 4.80
128 Zydus Lifesciences Limited Zydus Lanka (Private) Limited Subsidiary Company Sale of goods or services 31.50 Amount as approved by the Audit Committee. 31.50 0.00 0.00
129 Zydus Lifesciences Limited Zydus Lanka (Private) Limited Subsidiary Company Sale of goods or services 16.50 Amount as approved by the Audit Committee. 16.50 0.00 0.00
130 Zydus Lifesciences Limited Zydus Lanka (Private) Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 4.40 48.40
131 Zydus Lifesciences Limited Zydus Wellness Products Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 133.80 132.00
132 Zydus Lifesciences Limited Zydus Pharmaceuticals UK Ltd. Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 149.20 651.50
133 Zydus Lifesciences Limited Sterling Biotech Limited Joint Ventures Any other transaction Capital Advances 0.00 N.A. 2,500.00 0.00 0.00
134 Zydus Lifesciences Limited Sterling Biotech Limited Joint Ventures Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 70.80 135.50
135 Zydus Lifesciences Limited Zydus Hospira Oncology Private Limited Joint Ventures Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 18.70 0.00
136 Zydus Lifesciences Limited Zydus Hospira Oncology Private Limited Joint Ventures Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 2.10 3.00
137 Zydus Lifesciences Limited Vitely Corp Pvt Ltd (Formerly Known Vitely Bio LLP) Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.00 37.80
138 Zydus Lifesciences Limited Zydus Hospitals and Healthcare Research Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.20 0.90
139 Zydus Lifesciences Limited Cadmach Machinery Company Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 9.20 26.00
140 Zydus Lifesciences Limited Oneiro Chemicals Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 1,133.80 1,734.60
141 Zydus Lifesciences Limited Zydus Infrastructure Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 101.80 621.40
142 Zydus Lifesciences Limited Aleta Hospitals LLP [Formerly known as Zydus Hospitals (Vadodara) LLP] Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.00 0.00
143 Zydus Lifesciences Limited Dr. Sharvil P. Patel Key Managerial Personnel Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 1,956.20 2,711.30
144 Zydus Lifesciences Limited Mr. Ganesh N. Nayak Key Managerial Personnel Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 816.60 0.00
145 Zydus Lifesciences Limited Mr. Nitin D. Parekh Key Managerial Personnel Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 26.70 0.00
146 Zydus Lifesciences Limited Mr. Dhaval N. Soni Key Managerial Personnel Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 2.20 0.00
147 Zydus Lifesciences Limited Dialforhealth Unity Limited Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 25.50 26.60
148 Zydus Lifesciences Limited Zydus Pharmaceuticals UK Ltd. Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 2,280.50 24,530.80
149 Zydus Lifesciences Limited Zydus International Private Limited Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 1,25,824.40 1,30,757.30
150 Zydus Lifesciences Limited Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 93,962.00 97,647.00
151 Zydus Lifesciences Limited Sentynl Therapeutics Inc. Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 1,02,504.00 1,06,524.00
152 Zydus Lifesciences Limited Zydus Worldwide DMCC Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 82,627.50 25,451.10
153 Zydus Lifesciences Limited Zydus Healthcare Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 2,418.70 0.00
154 Zydus Lifesciences Limited Zydus Wellness Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 6.20 43.50
155 Zydus Lifesciences Limited Zydus Wellness Products Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 13.60 132.40
156 Zydus Lifesciences Limited German Remedies Pharma Private Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 52.60 75.50
157 Zydus Lifesciences Limited Zydus Animal Health and Investments Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 744.70 199.90
158 Zydus Lifesciences Limited Zydus Animal Health and Investments Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 12.40 36.40
159 Zydus Lifesciences Limited Zydus Pharmaceuticals Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 2,946.80 6,077.00
160 Zydus Lifesciences Limited Zydus VTEC Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 137.00
161 Zydus Lifesciences Limited Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 6,17,702.10 5,95,956.20
162 Zydus Lifesciences Limited Sentynl Therapeutics Inc. Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 159.10
163 Zydus Lifesciences Limited Viona Pharmaceuticals INC Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 17,967.00 22,845.40
164 Zydus Lifesciences Limited Zydus Therapeutics INC Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 172.70 552.30
165 Zydus Lifesciences Limited Zydus Healthcare Philippines Inc. Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 2,100.20 4,989.70
166 Zydus Lifesciences Limited Alidac Healthcare (Myanmar) Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 7,018.10 3,156.50
167 Zydus Lifesciences Limited Zydus Healthcare S.A. (Pty) Ltd Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 10,118.60 13,335.00
168 Zydus Lifesciences Limited Zydus Pharmaceuticals Mexico SA De CV Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 13,714.40 16,375.50
169 Zydus Lifesciences Limited Zydus Nikkho Farmaceutica Ltda. Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 17,911.70 22,527.30
170 Zydus Lifesciences Limited Zydus France, SAS Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 8,934.00 13,771.10
171 Zydus Lifesciences Limited Etna Biotech S.R.L. Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 763.90 1,025.90
172 Zydus Lifesciences Limited Zydus Pharmaceuticals UK Ltd. Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 955.20 685.10
173 Zydus Lifesciences Limited Laboratorios Combix S.L. Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 2,475.80 4,735.90
174 Zydus Lifesciences Limited Zydus Worldwide DMCC Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 4,085.60 2,398.20
175 Zydus Lifesciences Limited Zydus Takeda Healthcare Private Limited Joint Ventures Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 737.20
176 Zydus Lifesciences Limited Zydus Hospitals and Healthcare Research Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 75.30 70.20
177 Zydus Healthcare Limited Oneiro Chemicals Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 95.60 Amount as approved by the Audit Committee. 95.60 0.00 0.00
178 Zydus Healthcare Limited Zydus Nikkho Farmaceutica Ltda. Subsidiary Company Purchase of goods or services 1.60 Amount as approved by the Audit Committee. 1.60 0.00 0.00
179 Zydus Healthcare Limited Cadmach Machinery Company Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 1.10 Amount as approved by the Audit Committee. 1.10 0.00 0.00
180 Zydus Healthcare Limited Cadmach Machinery Company Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0.30 Amount as approved by the Audit Committee. 0.30 0.00 0.00
181 Zydus Healthcare Limited Mukesh M. Patel & Co., Proprietorship Firm Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 12.00 Amount as approved by the Audit Committee. 12.00 0.00 0.00
182 Zydus Healthcare Limited German Remedies Pharma Private Limited Subsidiary Company Sale of goods or services 568.00 Amount as approved by the Audit Committee. 568.00 0.00 0.00
183 Zydus Healthcare Limited Zydus Hospitals and Healthcare Research Private Limited Enterprises significantly influenced by Directors and/ or their relatives Sale of goods or services 172.20 Amount as approved by the Audit Committee. 172.20 0.00 0.00
184 Zydus Healthcare Limited Ramanbhai Foundation Enterprises significantly influenced by Directors and/ or their relatives Sale of goods or services 6.20 Amount as approved by the Audit Committee. 6.20 0.00 0.00
185 Zydus Healthcare Limited Zydus Wellness Products Limited Subsidiary Company Sale of goods or services 82.20 Amount as approved by the Audit Committee. 82.20 0.00 0.00
186 Zydus Healthcare Limited Dr. Sharvil P. Patel Key Managerial Personnel Any other transaction Director Sitting Fees 0.00 N.A. 4.00 0.00 0.00
187 Zydus Healthcare Limited Mr. Nitin D. Parekh Key Managerial Personnel Any other transaction Director Sitting Fees 0.00 N.A. 4.00 0.00 0.00
188 Zydus Healthcare Limited Sterling Biotech Limited Joint Ventures Purchase of goods or services 31.30 Amount as approved by the Audit Committee. 31.30 0.00 0.00
189 Zydus Healthcare Limited Sterling Biotech Limited Joint Ventures Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.00 15.50
190 Zydus Healthcare Limited Zydus Foundation Subsidiary Company Sale of goods or services 0.20 Amount as approved by the Audit Committee. 0.20 0.00 0.00
191 Zydus Healthcare Limited Zydus Foundation Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 1.00 1.30
192 Zydus Healthcare Limited Zydus Lifesciences Limited Parent Company Loan 0.00 N.A. 18,795.00 0.00 0.00 Loan 0.3500 5 Year Unsecured Business Purpose Textual Information(7)
193 Zydus Healthcare Limited Zydus Lifesciences Limited Parent Company Loan 0.00 N.A. 50,000.00 0.00 0.00 Loan 0.5500 5 Year Unsecured Business Purpose Textual Information(8)
194 Zydus Healthcare Limited Zydus Lifesciences Limited Parent Company Loan 0.00 N.A. 40,746.00 0.00 0.00 Loan 0.900 5 Year Unsecured Business Purpose Textual Information(9)
195 Zydus Healthcare Limited Zydus Pharmaceuticals Limited Subsidiary Company Loan 0.00 N.A. 16,500.00 0.00 0.00 Loan 0.5500 6 Month Unsecured Business Purpose Textual Information(10)
196 Zydus Healthcare Limited Zydus Pharmaceuticals Limited Subsidiary Company Loan 0.00 N.A. 16,500.00 0.00 0.00
197 Zydus Healthcare Limited Recon Pharmaceuticals and Investments Subsidiary Company Any other transaction Share of profit Received 0.00 N.A. 0.90 0.00 0.00
198 Zydus Healthcare Limited Zydus Healthcare Limited Employees Group Gratuity Scheme Post Employment Benefit Plans Any other transaction Contributions during the year [includes Employee's share and contribution] 0.00 N.A. 63.00 0.00 0.00
199 Zydus Healthcare Limited Cadmach Machinery Company Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 2.50 0.70
200 Zydus Healthcare Limited Zydus Nikkho Farmaceutica Ltda. Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 9.20 12.00
201 Zydus Healthcare Limited Ramanbhai Foundation Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 3.30 2.00
202 Zydus Healthcare Limited Zydus Hospitals and Healthcare Research Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 75.90 63.70
203 Zydus Wellness Limited Zydus Wellness Products Limited Subsidiary Company Purchase of goods or services 384.60 Amount as approved by the Audit Committee. 384.60 0.00 0.00
204 Zydus Wellness Limited Alidac UK Limited Subsidiary Company Sale of goods or services 137.00 Amount as approved by the Audit Committee. 137.00 0.00 0.00
205 Zydus Wellness Limited Mukesh M. Patel & Co., Proprietorship Firm Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 7.90 Amount as approved by the Audit Committee. 7.90 0.00 0.00
206 Zydus Wellness Limited Zydus Healthcare Limited Subsidiary Company Loan 0.00 N.A. 3,500.00 0.00 0.00
207 Zydus Wellness Limited Zydus Healthcare Limited Subsidiary Company Interest paid 0.00 N.A. 0.70 0.00 0.00
208 Zydus Wellness Limited Zydus Healthcare Limited Subsidiary Company Any other transaction Outstanding Payables - Loans 0.00 N.A. 0.00 3,580.70 0.00
209 Zydus Wellness Limited Zydus Wellness Products Limited Subsidiary Company Sale of goods or services 15,959.60 Amount as approved by the Audit Committee. 15,959.60 0.00 0.00
210 Zydus Wellness Limited Zydus Wellness International DMCC Subsidiary Company Sale of goods or services 316.90 Amount as approved by the Audit Committee. 316.90 0.00 0.00
211 Zydus Wellness Limited Zydus Wellness Products Limited Subsidiary Company Sale of fixed assets 1.40 Amount as approved by the Audit Committee. 1.40 0.00 0.00
212 Zydus Wellness Limited Zydus Wellness Products Limited Subsidiary Company Sale of goods or services 2,077.70 Amount as approved by the Audit Committee. 2,077.70 0.00 0.00
213 Zydus Wellness Limited Zydus Wellness Products Limited Subsidiary Company Interest paid 0.00 N.A. 332.00 0.00 0.00
214 Zydus Wellness Limited Zydus Wellness Products Limited Subsidiary Company Loan 0.00 N.A. 5,600.00 0.00 0.00
215 Zydus Wellness Limited Zydus Wellness Products Limited Subsidiary Company Loan 0.00 N.A. 5,650.00 0.00 0.00
216 Zydus Wellness Limited Zydus Wellness Products Limited Subsidiary Company Loan 0.00 N.A. 4,500.00 0.00 0.00
217 Zydus Wellness Limited Zydus Wellness International DMCC Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 32.10 Amount as approved by the Audit Committee. 32.10 0.00 0.00
218 Zydus Wellness Limited Dr. Sharvil P. Patel Key Managerial Personnel Any other transaction Director Sitting Fees 0.00 N.A. 4.00 0.00 0.00
219 Zydus Wellness Limited Mr. Tarun Arora Key Managerial Personnel Remuneration 0.00 N.A. 73.00 0.00 0.00
220 Zydus Wellness Limited Mr. Umesh V. Parikh Key Managerial Personnel Remuneration 0.00 N.A. 150.20 0.00 0.00
221 Zydus Wellness Limited Mr. Nandish P. Joshi Key Managerial Personnel Remuneration 0.00 N.A. 7.50 0.00 0.00
222 Zydus Wellness Limited Zydus Wellness International DMCC Subsidiary Company Interest received 0.00 N.A. 90.40 0.00 0.00
223 Zydus Wellness Limited Zydus Wellness International DMCC Subsidiary Company Loan 0.00 N.A. 856.70 0.00 0.00 Loan 2.400 5 Year Unsecured Business Purpose Textual Information(11)
224 Zydus Wellness Limited Zydus Wellness International DMCC Subsidiary Company Loan 0.00 N.A. 518.30 0.00 0.00 Loan 2.100 5 Year Unsecured Business Purpose Textual Information(12)
225 Zydus Wellness Limited Zydus Wellness International DMCC Subsidiary Company Loan 0.00 N.A. 303.00 0.00 0.00
226 Zydus Pharmaceuticals Limited Zydus Infrastructure Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of fixed assets 0.00 N.A. 15,204.80 0.00 0.00
227 Zydus Wellness Limited Mr. Umesh V. Parikh Key Managerial Personnel Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 49.90 0.00
228 Naturell (India) Private Limited Zydus Wellness Products Limited Subsidiary Company Purchase of goods or services 0.00 N.A. 38.40 0.00 0.00
229 Naturell (India) Private Limited Zydus Wellness Products Limited Subsidiary Company Sale of goods or services 0.00 N.A. 59.20 0.00 0.00
230 Naturell (India) Private Limited Zydus Wellness Products Limited Subsidiary Company Purchase of fixed assets 0.00 N.A. 5.10 0.00 0.00
231 Zydus Wellness Limited Zydus Wellness International DMCC Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 2,434.50 3,590.00
232 Zydus Wellness Limited Zydus Wellness Products Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 441.00 547.10
233 Zydus Wellness Limited Zydus Wellness Products Limited Subsidiary Company Any other transaction Outstanding Payables - Loans 0.00 N.A. 0.00 4,403.10 11,326.20
234 Zydus Wellness Limited Zydus Wellness International DMCC Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 354.00 447.20
235 Zydus Wellness Products Limited Zydus Healthcare Limited Subsidiary Company Purchase of goods or services 0.00 N.A. 27.30 0.00 0.00
236 Zydus Wellness Products Limited Cadmach Machinery Company Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of fixed assets 0.00 N.A. 1.10 0.00 0.00
237 Zydus Wellness Products Limited Mukesh M. Patel & Co., Proprietorship Firm Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0.00 N.A. 10.00 0.00 0.00
238 Zydus Wellness Products Limited Mr. Tarun Arora Key Managerial Personnel Remuneration 0.00 N.A. 368.70 0.00 0.00
239 Zydus Wellness Products Limited Zydus Wellness International DMCC Subsidiary Company Sale of goods or services 0.00 N.A. 1,387.40 0.00 0.00
240 Zydus Wellness Products Limited Zydus Healthcare Limited Subsidiary Company Sale of goods or services 0.00 N.A. 392.00 0.00 0.00
241 Zydus Wellness Products Limited Zydus Wellness International DMCC Subsidiary Company Sale of goods or services 0.00 N.A. 27.10 0.00 0.00
242 Zydus Wellness Products Limited Zydus Healthcare Limited Subsidiary Company Sale of goods or services 0.00 N.A. 106.50 0.00 0.00
243 Zydus Wellness Products Limited Zydus Wellness International DMCC Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 96.60 0.00 0.00
244 Zydus Wellness Products Limited Zydus Hospitals and Healthcare Research Private Limited Enterprises significantly influenced by Directors and/ or their relatives Sale of goods or services 0.00 N.A. 0.60 0.00 0.00
245 Zydus Wellness Products Limited LM Manufacturing India Private Limited Subsidiary Company Sale of goods or services 0.00 N.A. 24.00 0.00 0.00
246 Zydus Wellness Products Limited LM Manufacturing India Private Limited Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 4.30 0.00 0.00
247 Zydus Wellness Products Limited LM Manufacturing India Private Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.70 1.50
248 Zydus Wellness Products Limited Heinz India Private Limited Pension Fund Post Employment Benefit Plans Any other transaction Contributions during the year [includes Employee's share and contribution] 0.00 N.A. 16.30 0.00 0.00
249 Zydus Wellness Products Limited Zydus Wellness Sikkim Employees Group Gratuity Scheme Post Employment Benefit Plans Any other transaction Contributions during the year [includes Employee's share and contribution] 0.00 N.A. 156.30 0.00 0.00
250 Zydus Wellness Products Limited Cadmach Machinery Company Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0.00 N.A. 1.10 0.00 0.00
251 Zydus Wellness Products Limited Zydus Wellness International DMCC Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 2,138.70 1,762.10
252 Zydus Wellness Products Limited Zydus Healthcare Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 198.00 172.00
253 German Remedies Pharma Private Limited Zydus Healthcare Limited Subsidiary Company Sale of goods or services 0.00 N.A. 1,522.30 0.00 0.00
254 German Remedies Pharma Private Limited Zydus Foundation Subsidiary Company Sale of goods or services 0.00 N.A. 17.40 0.00 0.00
255 German Remedies Pharma Private Limited Zydus Foundation Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 5.90
256 German Remedies Pharma Private Limited Zydus Lifesciences Limited Parent Company Loan 0.00 N.A. 10,000.00 0.00 0.00 Loan 1.500 5 Year Unsecured Business Purpose Textual Information(13)
257 German Remedies Pharma Private Limited Recon Pharmaceuticals and Investments Subsidiary Company Any other transaction Share of profit Received 0.00 N.A. 0.10 0.00 0.00
258 German Remedies Pharma Private Limited Zydus Healthcare Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 28.30 175.50
259 Zydus Pharmaceuticals Limited Zydus Infrastructure Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0.00 N.A. 223.40 0.00 0.00
260 Zydus Pharmaceuticals Limited Zydus Animal Health and Investments Limited Subsidiary Company Purchase of goods or services 0.00 N.A. 0.70 0.00 0.00
261 Zydus Pharmaceuticals Limited Zydus Lifesciences Global FZE [UAE] Subsidiary Company Sale of goods or services 0.00 N.A. 44.70 0.00 0.00
262 Zydus Pharmaceuticals Limited Vitely Corp Pvt Ltd (Formerly Known Vitely Bio LLP) Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0.00 N.A. 5.10 0.00 0.00
263 Zydus Pharmaceuticals Limited Zydus Infrastructure Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 47.10 87.60
264 Zydus Pharmaceuticals Limited Zydus Lifesciences Global FZE [UAE] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 149.70 44.70
265 Zydus Animal Health and Investments Limited Cadmach Machinery Company Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0.00 N.A. 5.10 0.00 0.00
266 Zydus Animal Health and Investments Limited Dialforhealth Unity Limited Subsidiary Company Interest received 0.00 N.A. 0.00 0.00 0.00
267 Zydus Animal Health and Investments Limited Dialforhealth Unity Limited Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 1.10 1.10
268 Zydus Animal Health and Investments Limited Sterling Biotech Limited Joint Ventures Investment 0.00 N.A. 0.00 67,078.40 0.00
269 Zydus Animal Health and Investments Limited Biochem Pharmaceutical Private Limited Subsidiary Company Investment 0.00 N.A. 5.00 0.00 5.00 Investment 0 N.A Unsecured Business Purpose Textual Information(14)
270 Zydus Animal Health and Investments Limited Zydus Medtech Private Limited Subsidiary Company Interest received 0.00 N.A. 451.20 0.00 0.00
271 Zydus Animal Health and Investments Limited Zydus Medtech Private Limited Subsidiary Company Loan 0.00 N.A. 9,884.70 0.00 0.00 Loan 1.200 5 Year Unsecured Business Purpose Textual Information(15)
272 Zydus Animal Health and Investments Limited Zydus Infrastructure Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0.00 N.A. 57.00 0.00 0.00
273 Zydus Animal Health and Investments Limited ZyVet Animal Health Inc Subsidiary Company Sale of goods or services 0.00 N.A. 5,067.30 0.00 0.00
274 Zydus Animal Health and Investments Limited Viona Pharmaceuticals INC Subsidiary Company Interest received 0.00 N.A. 106.20 0.00 0.00
275 Zydus Animal Health and Investments Limited Zydus Lifesciences Limited Parent Company Loan 0.00 N.A. 74,979.00 0.00 0.00 Loan 1.200 5 Year Unsecured Business Purpose Textual Information(16)
276 Zydus Animal Health and Investments Limited ZyVet Animal Health Inc Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 1,727.40 4,029.70
277 Zydus Animal Health and Investments Limited Cadmach Machinery Company Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0.00 N.A. 2.60 0.00 0.00
278 Zydus Animal Health and Investments Limited Cadmach Machinery Company Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.20 4.90
279 Zydus Animal Health and Investments Limited Zydus Infrastructure Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 19.80 25.90
280 Zydus Animal Health and Investments Limited Viona Pharmaceuticals INC Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 4,271.00 4,438.50
281 Zydus Animal Health and Investments Limited Zydus Medtech Private Limited Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 10,329.20 20,362.90
282 Zydus Animal Health and Investments Limited ZyVet Animal Health Inc Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 8,601.50 4,280.40
283 Zydus Pharmaceuticals (USA) Inc. NAI Laboratories Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0.00 N.A. 258.30 0.00 0.00
284 Zydus Pharmaceuticals (USA) Inc. Navinta III, Inc Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0.00 N.A. 1,110.80 0.00 0.00
285 Zydus Pharmaceuticals (USA) Inc. Navinta LLC Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0.00 N.A. 2,474.10 0.00 0.00
286 Zydus Pharmaceuticals (USA) Inc. Navinta NV, Inc. Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0.00 N.A. 2,226.40 0.00 0.00
287 Zydus Pharmaceuticals (USA) Inc. Zydus Healthcare (USA) LLC Subsidiary Company Loan 0.00 N.A. 2,940.00 0.00 0.00
288 Zydus Pharmaceuticals (USA) Inc. Sentynl Therapeutics Inc. Subsidiary Company Sale of goods or services 0.00 N.A. 31.10 0.00 0.00
289 Zydus Pharmaceuticals (USA) Inc. Viona Pharmaceuticals INC Subsidiary Company Sale of goods or services 0.00 N.A. 25.90 0.00 0.00
290 Zydus Pharmaceuticals (USA) Inc. ZyVet Animal Health Inc Subsidiary Company Sale of goods or services 0.00 N.A. 25.90 0.00 0.00
291 Zydus Pharmaceuticals (USA) Inc. Zydus Lifesciences Global FZE [UAE] Subsidiary Company Purchase of goods or services 0.00 N.A. 40,794.60 0.00 0.00
292 Zydus Pharmaceuticals (USA) Inc. Zydus Lifesciences Global FZE [UAE] Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 11,845.20 0.00 0.00
293 Zydus Pharmaceuticals (USA) Inc. Zydus Lifesciences Global FZE [UAE] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 793.90
294 Zydus Pharmaceuticals (USA) Inc. Zydus Lifesciences Global FZE [UAE] Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 43,565.80 51,094.30
295 Zydus Pharmaceuticals (USA) Inc. Zydus Healthcare (USA) LLC Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 1.00 0.00 0.00
296 Zydus Pharmaceuticals (USA) Inc. Navinta LLC Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Reimbursement of Expenses paid 0.00 N.A. 115.60 0.00 0.00
297 Zydus Pharmaceuticals (USA) Inc. Navinta LLC Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 5.00 0.00 0.00
298 Zydus Pharmaceuticals (USA) Inc. Sentynl Therapeutics Inc. Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 8.20 0.00 0.00
299 Zydus Pharmaceuticals (USA) Inc. Viona Pharmaceuticals INC Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 12.20 0.00 0.00
300 Zydus Pharmaceuticals (USA) Inc. ZyVet Animal Health Inc Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 4.80 0.00 0.00
301 Zydus Pharmaceuticals (USA) Inc. Zydus Therapeutics INC Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 2.70 0.00 0.00
302 Zydus Pharmaceuticals (USA) Inc. Zydus Healthcare (USA) LLC Subsidiary Company Loan 0.00 N.A. 778.20 0.00 0.00 Loan 0.500 1 Year Unsecured Business Purpose Textual Information(17)
303 Zydus Pharmaceuticals (USA) Inc. Zydus Healthcare (USA) LLC Subsidiary Company Interest received 0.00 N.A. 58.20 0.00 0.00
304 Zydus Pharmaceuticals (USA) Inc. Sentynl Therapeutics Inc. Subsidiary Company Interest received 0.00 N.A. 663.40 0.00 0.00
305 Zydus Pharmaceuticals (USA) Inc. Viona Pharmaceuticals INC Subsidiary Company Interest received 0.00 N.A. 246.60 0.00 0.00
306 Zydus Pharmaceuticals (USA) Inc. ZyVet Animal Health Inc Subsidiary Company Interest received 0.00 N.A. 118.50 0.00 0.00
307 Zydus Pharmaceuticals (USA) Inc. Zydus Therapeutics INC Subsidiary Company Interest received 0.00 N.A. 2,139.20 0.00 0.00
308 Zydus Pharmaceuticals (USA) Inc. Zydus Pharmaceuticals Canada Inc. Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 1.30 0.00 0.00
309 Zydus Pharmaceuticals (USA) Inc. Zydus Pharmaceuticals Canada Inc. Subsidiary Company Interest received 0.00 N.A. 21.20 0.00 0.00
310 Zydus Pharmaceuticals (USA) Inc. Zydus Pharmaceuticals Canada Inc. Subsidiary Company Loan 0.00 N.A. 432.40 0.00 0.00 Loan 0.500 1 Year Unsecured Business Purpose Textual Information(18)
311 Zydus Pharmaceuticals (USA) Inc. Zydus Pharmaceuticals Canada Inc. Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 513.00 976.90
312 Zydus Pharmaceuticals (USA) Inc. Zydus Pharmaceuticals Canada Inc. Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 5.90 12.10
313 Zydus Pharmaceuticals (USA) Inc. Viona Pharmaceuticals INC Subsidiary Company Loan 0.00 N.A. 2,097.30 0.00 0.00 Loan 0.500 1 Year Unsecured Business Purpose Textual Information(19)
314 Zydus Pharmaceuticals (USA) Inc. ZyVet Animal Health Inc Subsidiary Company Loan 0.00 N.A. 1,988.80 0.00 0.00 Loan 0.500 1 Year Unsecured Business Purpose Textual Information(20)
315 Zydus Pharmaceuticals (USA) Inc. Zydus Therapeutics INC Subsidiary Company Loan 0.00 N.A. 14,751.50 0.00 0.00 Loan 0.500 1 Year Unsecured Business Purpose Textual Information(21)
316 Zydus Pharmaceuticals (USA) Inc. NAI Laboratories Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 158.40 265.30
317 Zydus Pharmaceuticals (USA) Inc. Navinta III, Inc Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 3.80 746.80
318 Zydus Pharmaceuticals (USA) Inc. Navinta LLC Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 464.40 1,327.60
319 Zydus Pharmaceuticals (USA) Inc. Navinta NV, Inc. Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 889.90 985.30
320 Zydus Pharmaceuticals (USA) Inc. Sentynl Therapeutics Inc. Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 27,654.70 28,761.80
321 Zydus Pharmaceuticals (USA) Inc. Viona Pharmaceuticals INC Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 9,414.30 11,932.90
322 Zydus Pharmaceuticals (USA) Inc. ZyVet Animal Health Inc Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 3,676.50 5,861.50
323 Zydus Pharmaceuticals (USA) Inc. Zydus Therapeutics INC Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 81,196.70 99,490.80
324 Zydus Pharmaceuticals (USA) Inc. Sentynl Therapeutics Inc. Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 325.50 24.40
325 Zydus Pharmaceuticals (USA) Inc. Viona Pharmaceuticals INC Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 83.60 71.40
326 Zydus Pharmaceuticals (USA) Inc. ZyVet Animal Health Inc Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 41.40 38.80
327 Zydus Pharmaceuticals (USA) Inc. Zylidac Bio LLC, USA Subsidiary Company Loan 0.00 N.A. 5.80 0.00 0.00 Loan 0.500 1 Year Unsecured Business Purpose Textual Information(22)
328 Zydus Pharmaceuticals (USA) Inc. Zylidac Bio LLC, USA Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 0.00 5.90
329 Zydus Pharmaceuticals (USA) Inc. Zydus Therapeutics INC Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 328.80 387.20
330 Zydus Worldwide DMCC Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Any other transaction Reimbursement of Expenses paid 0.00 N.A. 1,743.90 0.00 0.00
331 Zydus Worldwide DMCC Zydus Healthcare (USA) LLC Subsidiary Company Any other transaction Reimbursement of Expenses paid 0.00 N.A. 13.10 0.00 0.00
332 Zydus Worldwide DMCC Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Sale of goods or services 0.00 N.A. 10,760.90 0.00 0.00
333 Zydus Worldwide DMCC Zydus Netherlands B.V. Subsidiary Company Interest received 0.00 N.A. 227.30 0.00 0.00
334 Zydus Worldwide DMCC Alidac Healthcare (Myanmar) Limited Subsidiary Company Interest received 0.00 N.A. 130.10 0.00 0.00
335 Zydus Worldwide DMCC Zydus Netherlands B.V. Subsidiary Company Investment 0.00 N.A. 102.30 0.00 102.30 Investment 0 N.A Unsecured Business Purpose Textual Information(23)
336 Zydus Worldwide DMCC Zydus France, SAS Subsidiary Company Interest received 0.00 N.A. 45.10 0.00 0.00
337 Zydus Worldwide DMCC Zydus France, SAS Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 2,155.80 2,284.90
338 Zydus Worldwide DMCC Zydus International Private Limited Subsidiary Company Interest received 0.00 N.A. 1,253.70 0.00 0.00
339 Zydus Worldwide DMCC Alidac Healthcare (Myanmar) Limited Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 5,525.60 5,873.20
340 Zydus Worldwide DMCC Zydus Netherlands B.V. Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 9,823.50 10,437.30
341 Zydus Worldwide DMCC Zydus Lifesciences Global FZE [UAE] Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.00 1.10
342 Zydus Worldwide DMCC Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 2,882.10 1,791.10
343 Zydus Worldwide DMCC Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 7,967.70
344 Viona Pharmaceuticals INC Zydus Pharmaceuticals Canada Inc. Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.10 0.00
345 Viona Pharmaceuticals INC Zydus Worldwide DMCC Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 4.40 0.00
346 Zydus Healthcare (USA) LLC Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Sale of goods or services 0.00 N.A. 191.70 0.00 0.00
347 Zydus Healthcare (USA) LLC Zydus Therapeutics INC Subsidiary Company Sale of goods or services 0.00 N.A. 32.40 0.00 0.00
348 Zydus Healthcare (USA) LLC Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 34.20
349 Zydus Healthcare (USA) LLC Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Any other transaction Outstanding Payables - Loans 0.00 N.A. 0.00 2,137.50 0.00
350 Zydus Healthcare (USA) LLC Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 10.70 1.10
351 Zydus Healthcare (USA) LLC Zydus Therapeutics INC Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 1.10
352 Zydus Healthcare (USA) LLC Zydus Worldwide DMCC Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 2.00 15.50
353 ZyVet Animal Health Inc Zydus Animal Health and Investments Limited Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 2,176.50 0.00 0.00
354 Zydus Wellness International DMCC Zydus Worldwide DMCC Subsidiary Company Purchase of goods or services 0.00 N.A. 8.00 0.00 0.00
355 Zydus Wellness International DMCC Zydus Worldwide DMCC Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 13.10 8.70
356 Zydus International Private Limited RIC Chemicals LTD Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0.00 N.A. 16.40 0.00 0.00
357 Zydus International Private Limited Zydus Netherlands B.V. Subsidiary Company Interest received 0.00 N.A. 52.70 0.00 0.00
358 Zydus International Private Limited Zydus Healthcare S.A. (Pty) Ltd Subsidiary Company Interest received 0.00 N.A. 47.20 0.00 0.00
359 Zydus International Private Limited Zydus France, SAS Subsidiary Company Interest received 0.00 N.A. 70.10 0.00 0.00
360 Zydus International Private Limited Laboratorios Combix S.L. Subsidiary Company Interest received 0.00 N.A. 49.70 0.00 0.00
361 Zydus International Private Limited Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Loan 0.00 N.A. 54,993.40 0.00 0.00
362 Zydus International Private Limited Zydus Worldwide DMCC Subsidiary Company Loan 0.00 N.A. 51,856.20 0.00 0.00
363 Zydus International Private Limited Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Interest received 0.00 N.A. 223.10 0.00 0.00
364 Zydus International Private Limited Zydus Pharmaceuticals (USA) Inc. Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 54,205.00 0.00
365 Zydus International Private Limited Zydus Lifesciences Global FZE [UAE] Subsidiary Company Interest received 0.00 N.A. 4,239.70 0.00 0.00
366 Zydus International Private Limited Zydus Lifesciences Global FZE [UAE] Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 1,71,146.70 1,82,204.40
367 Zydus International Private Limited Zydus Worldwide DMCC Subsidiary Company Any other transaction Outstanding Payables - Loans 0.00 N.A. 0.00 54,171.60 4,270.50
368 Zydus International Private Limited Zydus Netherlands B.V. Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 2,561.10 2,935.40
369 Zydus International Private Limited Zydus Healthcare S.A. (Pty) Ltd Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 3,678.50 4,186.20
370 Zydus International Private Limited Zydus France, SAS Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 4,547.40 5,034.40
371 Zydus International Private Limited Laboratorios Combix S.L. Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 3,378.10 3,851.10
372 Zydus France, SAS Laboratorios Combix S.L. Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 0.20 0.00 0.00
373 Zydus France, SAS Laboratorios Combix S.L. Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 3.20 3.60
374 Zydus Healthcare S.A. (Pty) Ltd Alidac Pharmaceuticals SA (Pty) Ltd Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 4,208.50 4,661.20
375 Zydus Healthcare S.A. (Pty) Ltd Alidac Pharmaceuticals SA (Pty) Ltd Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 511.50 566.30
376 Script Management Services (Pty) Ltd Zydus Healthcare S.A. (Pty) Ltd Subsidiary Company Sale of goods or services 0.00 N.A. 4,501.20 0.00 0.00
377 Script Management Services (Pty) Ltd Zydus Healthcare S.A. (Pty) Ltd Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 3.10 0.00 0.00
378 Script Management Services (Pty) Ltd Zydus Healthcare S.A. (Pty) Ltd Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 69.00 145.20
379 Zydus Pharmaceuticals Mexico SA De CV Zydus Pharmaceuticals Mexico Services Company SA De C.V. Subsidiary Company Purchase of goods or services 0.00 N.A. 1.10 0.00 0.00
380 Zydus Healthcare Philippines Inc. RJ Conception Law Office Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0.00 N.A. 0.90 0.00 0.00
381 Alidac Healthcare (Myanmar) Limited Cadmach Machinery Company Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0.00 N.A. 9.20 0.00 0.00
382 Alidac Healthcare (Myanmar) Limited Cadmach Machinery Company Private Limited Enterprises significantly influenced by Directors and/ or their relatives Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 5.40 0.00
383 Zynext Ventures Pte. Ltd. Zynext Ventures USA LLC Subsidiary Company Investment 0.00 N.A. 0.00 7,808.70 0.00
384 Zydus Pharmaceuticals UK Ltd. LiqMeds Limited Subsidiary Company Interest received 0.00 N.A. 258.20 0.00 0.00
385 Zydus Pharmaceuticals UK Ltd. LM Manufacturing Limited Subsidiary Company Interest received 0.00 N.A. 479.40 0.00 0.00
386 Zydus Pharmaceuticals UK Ltd. Zydus France, SAS Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 8.40 0.00
387 Zydus Pharmaceuticals UK Ltd. LM Manufacturing Limited Subsidiary Company Loan 0.00 N.A. 9,046.80 0.00 0.00
388 Zydus Pharmaceuticals UK Ltd. LM Manufacturing Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 89.50 638.70
389 Zydus Pharmaceuticals UK Ltd. LM Manufacturing Limited Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 17,045.00 9,108.00
390 Zydus Pharmaceuticals UK Ltd. LiqMeds Limited Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 7,686.30 8,555.10
391 Zydus Lifesciences Global FZE [UAE] Zydus Lifesciences Limited Parent Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 30,844.10 50,540.10
392 Zydus Lifesciences Global FZE [UAE] Viona Pharmaceuticals INC Subsidiary Company Sale of goods or services 0.00 N.A. 3,138.10 0.00 0.00
393 Zydus Lifesciences Global FZE [UAE] Zydus Healthcare (USA) LLC Subsidiary Company Purchase of goods or services 0.00 N.A. 126.20 0.00 0.00
394 Zydus Lifesciences Global FZE [UAE] Zydus Healthcare (USA) LLC Subsidiary Company Any other transaction Reimbursement of Expenses paid 0.00 N.A. 78.40 0.00 0.00
395 Zydus Lifesciences Global FZE [UAE] Zydus Healthcare (USA) LLC Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 12.10 222.70
396 Zydus Lifesciences Global FZE [UAE] Viona Pharmaceuticals INC Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 1,664.50 2,665.20
397 LM Manufacturing Limited Zydus Pharmaceuticals UK Ltd. Subsidiary Company Any other transaction Reimbursement of Expenses Recovered 0.00 N.A. 313.10 0.00 0.00
398 LM Manufacturing Limited Zydus Pharmaceuticals UK Ltd. Subsidiary Company Sale of goods or services 0.00 N.A. 145.00 0.00 0.00
399 LiqMeds Worldwide Limited LM Manufacturing Limited Subsidiary Company Sale of goods or services 0.00 N.A. 20.90 0.00 0.00
400 LiqMeds Worldwide Limited LiqMeds Lifecare Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 1.10 197.70
401 LiqMeds Worldwide Limited LiqMeds Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 182.30 435.50
402 LM Manufacturing Limited Oncosol Limited Joint Ventures Purchase of goods or services 0.00 N.A. 81.20 0.00 0.00
403 LM Manufacturing Limited Oncosol Limited Joint Ventures Sale of goods or services 0.00 N.A. 7.00 0.00 0.00
404 LiqMeds Lifecare Limited Oncosol Limited Joint Ventures Sale of goods or services 0.00 N.A. 31.70 0.00 0.00
405 LM Manufacturing India Private Limited LM Manufacturing Limited Subsidiary Company Sale of goods or services 0.00 N.A. 359.10 0.00 0.00
406 LiqMeds Worldwide Limited LM Manufacturing Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 9,374.50 24,005.00
407 LiqMeds Worldwide Limited Oncosol Limited Joint Ventures Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 2.00 2.10
408 LM Manufacturing Limited Medsolutions (Europe) Limited Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 22.00 17.70
409 LM Manufacturing Limited Zydus Pharmaceuticals UK Ltd. Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 89.50 0.00
410 LM Manufacturing Limited Oncosol Limited Joint Ventures Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 84.60 16.20
411 LiqMeds Limited LM Manufacturing Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 3,398.60 4,847.70
412 LiqMeds Lifecare Limited LM Manufacturing Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 366.40 382.90
413 LM Manufacturing India Private Limited LM Manufacturing Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 127.00 92.30
414 LiqMeds Lifecare Limited LiqMeds Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 9.90 10.70
415 LiqMeds Lifecare Limited Medsolutions (Europe) Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 99.70 107.50
416 LiqMeds Lifecare Limited Oncosol Limited Joint Ventures Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 1,167.30 1,173.10
417 Medsolutions (Europe) Limited LiqMeds Worldwide Limited Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 128.00 138.00
418 Medsolutions (Europe) Limited Oncosol Limited Joint Ventures Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 4.80 5.20
419 Zydus Medtech Private Limited Zydus Infrastructure Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of fixed assets 0.00 N.A. 10,370.20 0.00 0.00
420 Zydus Medtech Private Limited Zydus Medtech France SAS Subsidiary Company Investment 0.00 N.A. 2,019.30 1.00 2,020.30 Investment 0 N.A Unsecured Business Purpose Textual Information(24)
421 Zydus Medtech Private Limited Zydus Hospitals and Healthcare Research Private Limited Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0.00 N.A. 4.00 0.00 0.00
422 Zydus Worldwide DMCC Zydus Lifesciences Global FZE [UAE] Subsidiary Company Any other transaction Reimbursement of Expenses paid 0.00 N.A. 43.30 0.00 0.00
423 Zydus Worldwide DMCC Zydus Lifesciences Global FZE [UAE] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 12,486.50 0.00
424 Zydus Healthcare S.A. (Pty) Ltd DI Consultancy Enterprises significantly influenced by Directors and/ or their relatives Purchase of goods or services 0.00 N.A. 116.10 0.00 0.00
425 Zydus Medtech France SAS Amplitude Surgical SAS Subsidiary Company Loan 0.00 N.A. 72,756.80 0.00 0.00 Loan 1.500 7 Year Unsecured Business Purpose Textual Information(25)
426 Zydus Medtech France SAS Amplitude Surgical SAS Subsidiary Company Interest received 0.00 N.A. 441.90 0.00 0.00
427 Zydus Medtech France SAS Amplitude Surgical SAS Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 0.00 76,055.30
428 Zydus Medtech France SAS Amplitude SAS [France] Subsidiary Company Loan 0.00 N.A. 13,212.20 0.00 0.00 Loan 1.500 7 Year Unsecured Business Purpose Textual Information(26)
429 Zydus Medtech France SAS Amplitude SAS [France] Subsidiary Company Interest received 0.00 N.A. 80.30 0.00 0.00
430 Zydus Medtech France SAS Amplitude SAS [France] Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 0.00 13,811.20
431 Amplitude SAS [France] SCI Les Tilleuls [France] Subsidiary Company Purchase of goods or services 0.00 N.A. 195.40 0.00 0.00
432 Amplitude SAS [France] SCI SOFAB FALLA [France] Subsidiary Company Purchase of goods or services 0.00 N.A. 94.70 0.00 0.00
433 Amplitude SAS [France] Amplitude Ile de France [France] Subsidiary Company Purchase of goods or services 0.00 N.A. 327.00 0.00 0.00
434 Amplitude SAS [France] Duotech Amplitude SAS [France] Subsidiary Company Purchase of goods or services 0.00 N.A. 147.60 0.00 0.00
435 Amplitude SAS [France] Amplitude Sud SAS [France] Subsidiary Company Purchase of goods or services 0.00 N.A. 235.30 0.00 0.00
436 Amplitude SAS [France] Amplitude Nord SAS [France] Subsidiary Company Purchase of goods or services 0.00 N.A. 263.20 0.00 0.00
437 Amplitude SAS [France] Ortho Santé (Amplitude Ouest) [France] Subsidiary Company Purchase of goods or services 0.00 N.A. 299.10 0.00 0.00
438 Amplitude SAS [France] Amplitude Australia Pty Ltd [Australia] Subsidiary Company Sale of goods or services 0.00 N.A. 551.30 0.00 0.00
439 Amplitude SAS [France] Amplitude South Africa Pty Ltd [South Africa] Subsidiary Company Sale of goods or services 0.00 N.A. 108.70 0.00 0.00
440 Amplitude SAS [France] Amplitude Latin America SA [Brazil] Subsidiary Company Sale of goods or services 0.00 N.A. 209.40 0.00 0.00
441 Amplitude SAS [France] Amplitude Benelux [Belgium] Subsidiary Company Sale of goods or services 0.00 N.A. 354.90 0.00 0.00
442 Amplitude SAS [France] Amplitude Suisse SA [Switzerland] Subsidiary Company Sale of goods or services 0.00 N.A. 45.90 0.00 0.00
443 Amplitude SAS [France] Amplitude GmbH [Germany] Subsidiary Company Sale of goods or services 0.00 N.A. 50.80 0.00 0.00
444 Amplitude SAS [France] Amplitude Ile de France [France] Subsidiary Company Sale of goods or services 0.00 N.A. 16.00 0.00 0.00
445 Amplitude SAS [France] Amplitude Sud SAS [France] Subsidiary Company Sale of goods or services 0.00 N.A. 5.00 0.00 0.00
446 Amplitude SAS [France] Amplitude Nord SAS [France] Subsidiary Company Sale of goods or services 0.00 N.A. 4.00 0.00 0.00
447 Amplitude SAS [France] Ortho Santé (Amplitude Ouest) [France] Subsidiary Company Sale of goods or services 0.00 N.A. 3.00 0.00 0.00
448 Amplitude SAS [France] Amplitude Benelux [Belgium] Subsidiary Company Sale of goods or services 0.00 N.A. 60.80 0.00 0.00
449 Amplitude SAS [France] Amplitude Orthopedics Corporation [USA] Subsidiary Company Interest received 0.00 N.A. 19.90 0.00 0.00
450 Amplitude SAS [France] Amplitude Australia Pty Ltd [Australia] Subsidiary Company Interest received 0.00 N.A. 64.80 0.00 0.00
451 Amplitude SAS [France] Amplitude South Africa Pty Ltd [South Africa] Subsidiary Company Interest received 0.00 N.A. 21.90 0.00 0.00
452 Amplitude SAS [France] Amplitude Benelux [Belgium] Subsidiary Company Interest received 0.00 N.A. 10.00 0.00 0.00
453 Amplitude SAS [France] Amplitude Suisse SA [Switzerland] Subsidiary Company Interest received 0.00 N.A. 5.00 0.00 0.00
454 Amplitude SAS [France] Amplitude GmbH [Germany] Subsidiary Company Interest received 0.00 N.A. 5.00 0.00 0.00
455 Amplitude SAS [France] SCI Les Tilleuls [France] Subsidiary Company Interest paid 0.00 N.A. 14.00 0.00 0.00
456 Amplitude SAS [France] SCI SOFAB FALLA [France] Subsidiary Company Interest paid 0.00 N.A. 1.00 0.00 0.00
457 Amplitude SAS [France] Amplitude Ile de France [France] Subsidiary Company Interest paid 0.00 N.A. 1.00 0.00 0.00
458 Amplitude SAS [France] Duotech Amplitude SAS [France] Subsidiary Company Interest paid 0.00 N.A. 2.00 0.00 0.00
459 Amplitude SAS [France] Amplitude Sud SAS [France] Subsidiary Company Interest paid 0.00 N.A. 3.00 0.00 0.00
460 Amplitude SAS [France] Amplitude Nord SAS [France] Subsidiary Company Interest paid 0.00 N.A. 1.00 0.00 0.00
461 Amplitude SAS [France] Ortho Santé (Amplitude Ouest) [France] Subsidiary Company Interest paid 0.00 N.A. 3.00 0.00 0.00
462 Amplitude SAS [France] SCI Les Tilleuls [France] Subsidiary Company Any other transaction Outstanding Payables - Loans 0.00 N.A. 0.00 0.00 2,890.00
463 Amplitude SAS [France] SCI SOFAB FALLA [France] Subsidiary Company Any other transaction Outstanding Payables - Loans 0.00 N.A. 0.00 0.00 108.40
464 Amplitude SAS [France] Amplitude Ile de France [France] Subsidiary Company Any other transaction Outstanding Payables - Loans 0.00 N.A. 0.00 0.00 353.30
465 Amplitude SAS [France] Duotech Amplitude SAS [France] Subsidiary Company Any other transaction Outstanding Payables - Loans 0.00 N.A. 0.00 0.00 402.30
466 Amplitude SAS [France] Amplitude Sud SAS [France] Subsidiary Company Any other transaction Outstanding Payables - Loans 0.00 N.A. 0.00 0.00 790.00
467 Amplitude SAS [France] Amplitude Nord SAS [France] Subsidiary Company Any other transaction Outstanding Payables - Loans 0.00 N.A. 0.00 0.00 302.20
468 Amplitude SAS [France] Ortho Santé (Amplitude Ouest) [France] Subsidiary Company Any other transaction Outstanding Payables - Loans 0.00 N.A. 0.00 0.00 683.70
469 Amplitude SAS [France] Amplitude Latin America SA [Brazil] Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.00 2.10
470 Amplitude SAS [France] SCI Les Tilleuls [France] Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.00 140.70
471 Amplitude SAS [France] SCI SOFAB FALLA [France] Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.00 42.70
472 Amplitude SAS [France] Amplitude Ile de France [France] Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.00 406.50
473 Amplitude SAS [France] Duotech Amplitude SAS [France] Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.00 188.60
474 Amplitude SAS [France] Amplitude Sud SAS [France] Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.00 300.20
475 Amplitude SAS [France] Amplitude Nord SAS [France] Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.00 336.60
476 Amplitude SAS [France] Ortho Santé (Amplitude Ouest) [France] Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.00 380.40
477 Amplitude SAS [France] Amplitude Orthopedics Corporation [USA] Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 0.00 6,380.30
478 Amplitude SAS [France] Amplitude Australia Pty Ltd [Australia] Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 0.00 20,352.10
479 Amplitude SAS [France] Amplitude South Africa Pty Ltd [South Africa] Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 0.00 4,919.20
480 Amplitude SAS [France] SCI Les Tilleuls [France] Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 0.00 224.10
481 Amplitude SAS [France] Amplitude Benelux [Belgium] Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 0.00 2,208.40
482 Amplitude SAS [France] Amplitude Suisse SA [Switzerland] Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 0.00 1,367.40
483 Amplitude SAS [France] Amplitude GmbH [Germany] Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 0.00 978.60
484 Amplitude SAS [France] Amplitude Australia Pty Ltd [Australia] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 992.20
485 Amplitude SAS [France] Amplitude South Africa Pty Ltd [South Africa] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 115.70
486 Amplitude SAS [France] Amplitude Latin America SA [Brazil] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 2,406.40
487 Amplitude SAS [France] Amplitude Ile de France [France] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 20.80
488 Amplitude SAS [France] Duotech Amplitude SAS [France] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 1.00
489 Amplitude SAS [France] Amplitude Sud SAS [France] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 6.30
490 Amplitude SAS [France] Amplitude Nord SAS [France] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 7.30
491 Amplitude SAS [France] Ortho Santé (Amplitude Ouest) [France] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 534.60
492 Amplitude SAS [France] Amplitude Benelux [Belgium] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 465.90
493 Amplitude SAS [France] Amplitude Suisse SA [Switzerland] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 47.90
494 Amplitude SAS [France] Amplitude GmbH [Germany] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 7.30
495 Amplitude Surgical SAS Amplitude SAS [France] Subsidiary Company Sale of goods or services 0.00 N.A. 324.00 0.00 0.00
496 Amplitude Surgical SAS Amplitude SAS [France] Subsidiary Company Interest received 0.00 N.A. 173.50 0.00 0.00
497 Amplitude Surgical SAS SCI Les Tilleuls [France] Subsidiary Company Interest received 0.00 N.A. 12.00 0.00 0.00
498 Amplitude Surgical SAS Amplitude SAS [France] Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 0.00 35,261.80
499 Amplitude Surgical SAS SCI Les Tilleuls [France] Subsidiary Company Any other transaction Outstanding Receivables - Loans 0.00 N.A. 0.00 0.00 2,605.50
500 Amplitude Ile de France [France] Amplitude Sud SAS [France] Subsidiary Company Purchase of goods or services 0.00 N.A. 1.00 0.00 0.00
501 Amplitude Ile de France [France] Duotech Amplitude SAS [France] Subsidiary Company Sale of goods or services 0.00 N.A. 2.00 0.00 0.00
502 Amplitude Ile de France [France] Amplitude Sud SAS [France] Subsidiary Company Sale of goods or services 0.00 N.A. 1.00 0.00 0.00
503 Amplitude Ile de France [France] Amplitude Nord SAS [France] Subsidiary Company Sale of goods or services 0.00 N.A. 1.00 0.00 0.00
504 Amplitude Ile de France [France] Amplitude Sud SAS [France] Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.00 2.10
505 Amplitude Ile de France [France] Duotech Amplitude SAS [France] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 3.10
506 Amplitude Ile de France [France] Amplitude Sud SAS [France] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 2.10
507 Amplitude Ile de France [France] Amplitude Nord SAS [France] Subsidiary Company Any other transaction Outstanding Receivables - Other than loans 0.00 N.A. 0.00 0.00 2.10
508 Comfort Click Softech Pvt. Ltd. Comfort Click Limited (UK) Subsidiary Company Sale of goods or services 0.00 N.A. 642.60 0.00 0.00
509 Comfort Click Limited (UK) Comfort Click Limited (Ireland) Subsidiary Company Sale of goods or services 0.00 N.A. 23.80 0.00 0.00
510 Comfort Click Limited (UK) Comfort Click Limited (Ireland) Subsidiary Company Any other transaction Reimbursement of Expenses paid 0.00 N.A. 65.10 0.00 0.00
511 Comfort Click Limited (UK) Comfort Click Limited (Ireland) Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.00 1,291.00
512 Comfort Click Limited (UK) Comfort Click Softech Pvt. Ltd. Subsidiary Company Any other transaction Outstanding Payables - Other than loans 0.00 N.A. 0.00 0.00 93.80
Total value of transaction during the reporting period 14,00,289.40



Text Block

Textual Information(1) Receivables / Payables other than loans represents combined balance against sales / purchase pertaining to goods/ propoerty, plant and equipment / various services / reimbursement of expenses. Hence shown separately.
Textual Information(2) Purchase / Subscription of Investments. Opening and closing balance are not given where there was no transaction of Investment during the half year ended September 30, 2025.
Textual Information(3) Loan Given 6 Month SOFR + 240 BPS
Textual Information(4) Loan Given 6 Month SONIA + 190 BPS
Textual Information(5) Purchase / Subscription of Investments.
Textual Information(6) Purchase / Subscription of Investments.
Textual Information(7) Loan Given 1 Month T Bill + 35 BPS
Textual Information(8) Loan Given 1 Month T Bill + 55 BPS
Textual Information(9) Loan Given 1 Month T Bill + 90 BPS
Textual Information(10) Loan Given 6 Month T Bill + 55 BPS
Textual Information(11) Loan Given 1 Year SOFR + 240 BPS
Textual Information(12) Loan Given 1 Year SOFR + 210 BPS
Textual Information(13) Loan Given 1 Month T Bill + 150 BPS
Textual Information(14) Purchase / Subscription of Investments.
Textual Information(15) Loan Given 1 Month T Bill + 120 BPS
Textual Information(16) Loan Given 1 Month T Bill + 120 BPS
Textual Information(17) Loan Given 6 Month SOFR + 50 BPS
Textual Information(18) Loan Given 3 Month SOFR + 50 BPS
Textual Information(19) Loan Given 6 Month SOFR + 50 BPS
Textual Information(20) Loan Given 6 Month SOFR + 50 BPS
Textual Information(21) Loan Given 6 Month SOFR + 50 BPS
Textual Information(22) Loan Given 6 Month SOFR + 50 BPS
Textual Information(23) Purchase / Subscription of Investments.
Textual Information(24) Purchase / Subscription of Investments.
Textual Information(25) Loan Given 3 Month EURIBOR + 150 BPS
Textual Information(26) Loan Given 3 Month EURIBOR + 150 BPS